News Releases

September 27, 2024

MSD Animal Health Reaffirms its Commitment to Eliminating Rabies with its 6 Millionth Vaccine Donation Through the Afya Program

RAHWAY, N.J., August 29, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than six million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. “Many communities where rabies outbreaks persist, have limited access to resources and vaccines,” said Ingrid Deuzeman, […]

September 25, 2024

MSD Animal Health Receives Marketing Authorization from the European Medicines Agency for PORCILIS® PCV M Hyo ID, an Intradermal Vaccine for Use in Swine

New vaccine protects against two of the most common swine diseases, while offering animal-friendly and efficient administration through IDAL® device technology Rahway, NJ, Sept. 25, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency has granted the marketing authorization in the […]

September 24, 2024

MSD Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus

Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly USDA-approved NOBIVAC® NXT vaccine platform to include a best in class solution […]

August 9, 2024

MSD Animal Health Launches SenseHub™ Dairy Youngstock with Group Housing Capability to Provide Farmers with Actionable Insights to Make More Informed Decisions

Launch coincides with new updates to SenseHub Ecosystem and SenseHub Dairy aimed at increasing capabilities and efficiencies for herds of all size Rahway, NJ. August 09, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the availability of SenseHub™ Dairy Youngstock for preweaned calves in individual […]

July 9, 2024

MSD Animal Health Completes Acquisition of Elanco’s Aqua Business

Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits RAHWAY, N.J., July 9, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN).. The completion of this acquisition […]

June 25, 2024

USDA Approves MSD Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease RAHWAY, N.J., June 25, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the USDA approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of […]

June 17, 2024

MSD Animal Health Announces Launch and Availability of NOBIVAC® NXT Rabies in Canada

First-of-its-kind line of vaccines leverages state-of-the-art RNA-particle technology to protect cats and dogs from rabies RAHWAY, N.J., June 17, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the launch and availability of the NOBIVAC® NXT Rabies portfolio – consisting of NOBIVAC® NXT Feline-3 Rabies and […]

June 4, 2024

MSD Animal Health Presents New Data Highlighting Commitment to Swine Innovation at the 27th International Pig Veterinary Society Congress and 15th European Symposium of Porcine Health Management

Rahway, N.J., June 4, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of more than 30 studies at the 27th International Pig Veterinary Society Congress (IVPS) and 15th European Symposium of Porcine Health Management (ESPHM), highlighting new research across the company’s broad swine […]

May 24, 2024

MSD Animal Health Receives Marketing Authorization from European Commission for INNOVAX®-ND-H5 Vaccine for Use in Chickens

First centrally registered vaccine in the European Union against the currently circulating avian influenza virus strains of clade 2.3.4.4b RAHWAY, N.J., May 24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for the INNOVAX®-ND-H5 vaccine for […]

May 21, 2024

External Parasites Negatively Impact Cattle Health, Performance and Production, Highlighting the Need for Year-Round Parasite Management and Control

Data Presented at the World Buiatrics Congress 2024 RAHWAY, N.J., May 21, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced findings on the global economic impact of parasites in cattle, concluding that parasite management is critical for farmers to produce enough beef to meet world […]